Caprolactam Chemicals recommends Raman S. Shah & Co as statutory auditors

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Caprolactam Chemicals recommends M/s. Raman S. Shah & Co as statutory auditors
  • Proposed audit fees are ₹110000 plus applicable taxes and expenses
  • Appointment is subject to approval at the 37th Annual General Meeting
  • E-voting for the AGM runs from September 24 to September 27, 2026
powered bylight_fuzz_icon
49726923

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals Limited has recommended the appointment of M/s. Raman S. Shah & Co as its statutory auditors. The Board of Directors approved the proposal during a meeting held on August 31, 2026.

The recommendation follows advice from the Audit Committee, which cited the firm’s professional expertise and suitability for the company’s audit requirements. The proposed engagement is subject to shareholder approval at the ensuing Annual General Meeting (AGM).

Auditor Details

The firm, bearing Registration No. 111919W, is led by signing partner Raman S. Shah (Membership No. 033272). The proposed audit fees are set at ₹110000 plus applicable taxes and reimbursement of out-of-pocket expenses.

Particulars Details
Audit Firm M/s. Raman S. Shah & Co
Signing Partner Raman S. Shah
Proposed Fees ₹110000 plus taxes
Term From conclusion of ensuing AGM until conclusion of 42nd AGM

The appointment requires receipt of requisite consent and eligibility certificates confirming compliance with the Companies Act, 2013. The firm has no relationship with the company’s directors or key managerial personnel.

AGM Logistics

The board also approved logistical arrangements for the 37th AGM, scheduled for September 28, 2026, at 10:30 am. Purva Sharegistry (India) Pvt. Ltd. has been appointed to handle e-voting services.

Mr. Rahul Shivji Gori was appointed as the scrutinizer for the e-voting process. The record date for determining voting eligibility is September 21, 2026. Shareholders may cast votes electronically from 9:00 am on Thursday, September 24, 2026, to 5:00 pm on Sunday, September 27, 2026.

Historical Stock Returns for Caprolactam Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%-3.90%0.0%+2.17%0.0%

How might the appointment of M/s. Raman S. Shah & Co influence Caprolactam Chemicals' future financial reporting standards and investor confidence?

What are the potential implications of the ₹110,000 audit fee structure for the company's operational costs and profitability margins in the upcoming fiscal year?

Could the specific timeline for the 37th AGM and e-voting process impact shareholder participation rates or the outcome of key resolutions?

like16
dislike

Caprolactam Chemicals Q1 Results: Net loss widens to ₹98.86 lakh

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Caprolactam Chemicals posted a Q1 FY26 net loss of ₹98.86 lakh, contrasting with a ₹36.21 lakh profit in Q1 FY25. Revenue from operations declined to ₹46.77 lakh from ₹256.47 lakh. Fixed costs like finance and depreciation remained high relative to the reduced revenue base.

powered bylight_fuzz_icon
48157299

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals Limited Caprolactam Chemicals reported a standalone net loss of ₹98.86 lakh for the quarter ended June 30, 2026, compared to a net profit of ₹36.21 lakh in the same period of FY25. The company’s revenue from operations fell significantly to ₹46.77 lakh, down from ₹256.47 lakh in Q1 FY25.

The Board of Directors approved the unaudited standalone financial results in a meeting held on August 13, 2026. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Pulindra Patel & Co., in compliance with SEBI Listing Regulations.

Financial Performance

The company’s total income for the quarter stood at ₹46.86 lakh, including other income of ₹0.09 lakh. Total expenses amounted to ₹145.74 lakh, resulting in a pre-tax loss of ₹98.88 lakh. After accounting for a tax credit of ₹0.02 lakh, the net loss after tax was ₹98.86 lakh.

Metric Q1 FY26 (₹ Lakh) Q1 FY25 (₹ Lakh)
Revenue from Operations 46.77 256.47
Total Income 46.86 256.56
Total Expenses 145.74 208.01
Profit / (Loss) Before Tax (98.88) 48.55
Net Profit / (Loss) After Tax (98.86) 36.21
Basic EPS (₹) (2.15) 0.79

What the Numbers Show

A notable divergence exists between the decline in top-line revenue and the persistence of fixed costs. While revenue from operations dropped by over 80% year-on-year, finance costs remained relatively stable at ₹17.76 lakh in Q1 FY26 versus ₹18.25 lakh in Q1 FY25. Similarly, depreciation expenses were ₹36.71 lakh, only slightly lower than the ₹38.02 lakh recorded in the prior year period. This rigidity in cost structure amplified the impact of the revenue contraction on the bottom line, turning a profitable quarter into a significant loss.

Historical Stock Returns for Caprolactam Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%-3.90%0.0%+2.17%0.0%

What specific operational or market factors drove the 80% year-on-year decline in revenue for Caprolactam Chemicals?

How does the company plan to address the rigidity in fixed costs, particularly depreciation and finance expenses, amidst falling revenues?

Will Caprolactam Chemicals need to raise additional capital to sustain operations given the shift from profit to a significant net loss?

like18
dislike

More News on Caprolactam Chemicals

1 Year Returns:+2.17%